Cart
sales@molnova.com
DRAK2-IN-16
CAS No. 871837-60-4
DRAK2-IN-16( —— )
Catalog No. M16339 CAS No. 871837-60-4
DRAK2-IN-116 is a potent, selective DRAK2 inhibitor with IC50 of 3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 194 | Get Quote |
|
| 50MG | 896 | Get Quote |
|
| 100MG | 1566 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDRAK2-IN-16
-
NoteResearch use only, not for human use.
-
Brief DescriptionDRAK2-IN-116 is a potent, selective DRAK2 inhibitor with IC50 of 3 nM.
-
DescriptionDRAK2-IN-116 is a potent, selective DRAK2 inhibitor with IC50 of 3 nM, shows weak inhibition for DRAK1 (IC50=51 nM) and no significant activity against DAPK1/2/3 (IC50>1 uM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetDAPK
-
RecptorDAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number871837-60-4
-
Formula Weight376.416
-
Molecular FormulaC21H20N4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (265.67 mM)
-
SMILESCCCCC(NC1=CC2=C(NC(/C2=C3NC4=C(C=CC=C4)C\3=N\O)=O)C=C1)=O
-
Chemical NameN-((2Z,3E)-3-(hydroxyimino)-2'-oxo-[2,3'-biindolinylidene]-5'-yl)pentanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jung ME, et al. Bioorg Med Chem Lett. 2016 Jun 1;26(11):2719-23.
molnova catalog
related products
-
DAPK-IN-2
DAPK-IN-2 (WAY-380496) is a DAPK inhibitor. DAPK-IN-2 has potential anticancer activity, regulates autophagy and can be used to study cerebral infarction and ischemic diseases.
-
HS94
HS94 (DAPK3 inhibitor HS94) is a selective DAPK3 inhibitor with Ki of 126 nM, >20-fold selectivity over Pim kinases.
-
DRAK2-IN-16
DRAK2-IN-116 is a potent, selective DRAK2 inhibitor with IC50 of 3 nM.
